Nice Insight has begun compiling primary and secondary data to create a comprehensive report on the dynamic development and manufacturing market for active pharmaceutical ingredients. The report will explore innovations in modalities and synthesis systems, manufacturing equipment and processes, automation, and analytics for APIs, including next-generation APIs, highly potent and controlled substances, and generics. The report will include a proprietary pricing study providing pricing data for a full range of line items associated with outsourced API development and manufacturing services.
Business Development Director
for Advanced Therapies
Account & Sales Executive
Digital Marketing & Account Director, Europe